Association of HindIII and PvuII genetic polymorphisms of lipoprotein lipase with lipid metabolism and macrovascular events in type 2 diabetic patients

Diabetes and Metabolism

Volumn 32, Issue 3, 2006, Pages 262-269

  Socquard, E ^a   Durlach, A ^b   Clavel, C ^b   Nazeyrollas, P ^a   Durlach, V ^a  

^a SERVICE DE DERMATOLOGIE   (France)

^b HÔPITAL MAISON BLANCHE   (France)

Author keywords

Coronary heart disease; HindIII and PvuII polymorphisms; Lipoprotein lipase; Triglycerides and HDL cholesterol; Type 2 diabetes

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

ADULT; AGED; ALLELE; ARTICLE; BODY MASS; CARDIAC PATIENT; CAUCASIAN; DIABETIC MICROANGIOPATHY; DNA POLYMORPHISM; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARAMETER; POPULATION RESEARCH; PREVALENCE; RISK ASSESSMENT;

EID: 33745671272     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70278-1     Document Type: Article

References (52)

1. Pyörälä K, Laakso M, Uusitupa M. Diabetes and atherosclerosis an epidemiological view. Diabetes Metab Rev 1987;3:463-524.
2. Dunn FL. Hyperlipidemia in diabetes mellitus. Diabet Metab Rev 1990;6:47-61.
3. Howard BV. Lipoprotein metabolism in diabetes mellitus. J Lipid Res 1987;28:613-28.
4. Eckel RH. Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. New Engl J Med 1989;323:1060-8.
5. Murphy V, Julien P, Gagné C. Molecular pathobiology of the human lipoprotein lipase gene. Pharmacol Ther 1996;70:101-35.
6. Dobrian AD, Lazar V, Sinescu C, et al. 2000 Diabetic state induces lipid loading and altered expression and secretion of lipoprotein lipase in human monocyte-derived macrophages. Atherosclerosis 1996;153:191-201.
7. Pentikäinen MO, Oksjoki R, Oorni R, et al. Lipoprotein lipase in the arterial wall. Linking LDL to the arterial extracellular matrix and much more. Arterioscler Thromb Vasc Biol 2002;22:211-7.
8. Anderson JL, King GJ, Bair TL, et al. Association of lipoprotein lipase gene polymorphisms with coronary disease. J Am Coll Cardiol 1999; 33:1013-20.
9. Fisher RM, Humphries SE, Talmud PJ. Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis. Atherosclerosis 1997;135: 145-59.
10. Hokanson JE. Lipoprotein lipase gene variants and risk of coronary disease: a quantitative analysis of population-based studies. Int J Clin Lab Res 1997;27:24-34.
11. Minnich A, Baloukas J, Roederer G, et al. Lipoprotein lipase gene mutations in coronary artery disease. Can J Cardiol 1998;14:711-6.
12. Deeb SS, Peng R. Structure of the human lipoprotein lipase gene. Biochemistry, 1989;28:4131-5.
13. Oka K, Tkalcevic GT, Nakano T, et al. Structure and polymorphic map of human lipoprotein lipase gene. Biochem Biophys Acta 1990;1049:21-6.
14. McDonnell MG, Young IS, Nicholls DP, et al. Genetics of the lipoprotein lipase gene and hypertriglyceridaemia. Br J Biomed Sci 2003;60:84-8.
15. Wittrup HH, Tybjaerg-Hansen A, Nordestgaard BG. Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis. Circulation 1999;99:2901-7.
16. Zhang Q, Cavallero E, Hoffmann MM, et al. Mutations at the lipoprotein lipase gene locus in subjects with diabetes mellitus, obesity and lipaemia. Clin Sci 1997;93:335-41.
17. Jemaa R, Tuzet S, Portos C, et al. Lipoprotein lipase gene polymorphisms: associations with hypertriglyceridemia and body mass index in obese people. Int J Obes 1995;19:270-4.
18. Nicklas BJ, Ferrell RE, Rogus EM, et al. Lipoprotein lipase gene variation is associated with adipose tissue lipoprotein lipase activity, and lipoprotein lipid and glucose concentrations in overweight postmenopausal women. Hum Genet 2000;106:420-4.
19. Chamberlain JC, Thorn JA, Oka K. DNA polymorphisms at the lipoprotein lipase gene: associations in normal and hypertriglyceridaemic subjects. Atherosclerosis 1989;79:85-91.
20. Gerdes C, Gerdes LU, Hansen PS, et al. Polymorphisms in the lipoprotein lipase gene and their associations with plasma lipid concentrations in 40-year-old Danish men. Circulation 1995;92:1765-9.
21. Mitchell RJ, Earl L, Bray P, Fripp YJ, Williams J. DNA polymorphisms at the lipoprotein lipase gene and their associations with quantitative variation in plasma high-density lipoproteins and triacylglycerides. Hum Biol 1994;66:383-97.
22. Peacok RE, Hamsten A, Nilsson-Ehle, et al. Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. Atheroslerosis 1992;97:171-85.
23. Ahn YI, Kamboh MI, Hamman RF, et al. Two DNA polymorphisms in the lipoprotein lipase gene and their associations with factors related to cardiovascular disease. J Lipid Res 1993;34:421-8.
24. Gambino R, Scaglione L, Alemanno N, et al. M. Human lipoprotein lipase HindIII polymorphism in young patients with myocardial infarction. Metabolism 1999;48:1157-61.
25. Jemaa R, Fumeron F, Poirier O. Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. J Lipid Res 1995;36:2141-6.
26. Mattu RK, Needham EWA, Morgan R, et al. DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a welsh population. Arterioscler Thromb 1994;14:109-7.
27. Rios DL, Vargas AF, Ewald GM, et al. Common variants in the lipoprotein lipase gene in Brazil: association with lipids and angiographically assessed coronary atherosclerosis. Clin Chem Lab Med 2003;41:1351-6.
28. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density-lipoprotein cholesterol level: a metaanalysis of population-based prospective studies. J Cardiovasc Risk 1996;3:213-9.
29. Jeppesen J, Ole Hein H, Suadicani, et al. Triglyceride concentration and ischemic heart disease. An eight-year follow-up in the Copenhagen Male Study. Circulation 1998;97:1029-36.
30. West KM, Ahuja MM, Bennett PH. The role of circulating glucose and triglyceride concentrations and the interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care 1983;6:361-9.
31. Fontbonne A, Eschwège E, Cambien F. Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes: results from the 11-year follow-up of the Paris prospective study. Diabetologia 1989;32:300-4.
32. Lewis GF, Steiner G. Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 1996;12:37-56.
33. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose tolerance. Diabetes 1979;28:1039-57.
34. Stein Y, Stein O. Lipoprotein lipase and atherosclerosis. Atherosclerosis 2003;170:1-9.
35. Humphries SE, Nicaud V, Margalef J, et al. Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS). Arterioscler Thromb Vasc Biol 1998;18:526-34.
36. Garenc C, Pérusse E, Gagnon J, et al. Linkage and association studies of the lipoprotein lipase gene with postheparin plasma lipase activities, body fat, and plasma lipid and lipoprotein concentrations: The HERITAGE Family Study. Metabolism 2000;49:432-9.
37. Wittrup HH, Nordestgaard BG, Steffensen R, et al. Effect of gender on phenotypic expression of the S447X mutation in LPL: the Copenhagen City Heart Study. Atherosclerosis 2002;165:119-26.
38. Biesbroeck RC, Albers JJ, Wahl PW, et al. Abnormal composition of high density lipoproteins in non-insulin dependent diabetes. Diabetes 1982;31:126-31.
39. Bagdade JD, Buchanan WE, Kuusi T, et al. Persistent abnormalities in lipoprotein composition in non insulin dependent diabetes after intensive insulin therapy. Arteriosclerosis 1990;10:232-9.
40. Reckless JPD, Betteridge DJ, Wu P, et al. High density and low density lipoproteins and prevalence of vascular disease in diabetes mellitus. BMJ 1978;1:883-6.
41. Seviour PW, Teal TK, Richmond W, et al. Serum lipids, lipoproteins and macrovascular disease in non insulin-dependent diabetics: a possible new approach to prevention. Diabet Med 1988;5:166-71.
42. Stewart MW, Laker MF, Dyer RG, et al. Lipoprotein compositional abnormalities and insulin resistance in type 2 diabetic patients with mild hyperlipidemia. Arterioscler Thromb 1993;13:1046-52.
43. Wang XL, McCredie RM, Wilcken DEL. Common DNA polymorphisms at the lipoprotein lipase gene. Association with severity of coronary artery disease and diabetes. Circulation 1996;93:1339-45.
44. Pruneta-Deloche V, Sassolas A, Dallinga-Thie GM, et al. Alteration in lipoprotein lipase activity bound to triglyceride-rich lipoproteins in the post-prandial state in type 2 diabetes. J Lipid Res 2004;45:859-65.
45. Ma YQ, Thomas GN, Ng MCY, et al. The lipoprotein lipase gene HindIII polymorphism is associated with lipid levels in early-onset type 2 diabetic patients. Metabolism 2003;52:338-43.
46. Behr SR, Kraemer FB. Insulin deficiency decreases lipoprotein lipase secretion by murine macrophages. Diabetes 1988;37:1076-81.
47. Pruneta V, Autran D, Ponsin G. Ex vivo measurement of lipoprotein lipase-dependent very low density lipoprotein (VLDL)-triglyceride hydrolysis in human VLDL: an alternative to the postheparin assay of lipoprotein lipase activity? J Clin Endocrinol Metab 2001;86:797-803.
48. Henderson HE, Kastelein JJP, Zwinderman AH, et al. Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteins. J Lipid Res 1999;40:735-43.
49. Kastelein JJP, Jukema JW, Zwinderman AH, et al. Lipoprotein lipase activity is associated with severity of angina pectoris. Circulation 2000;102:1629-33.
50. Hitsumoto T, Ohsawa H, Uchi T. Preheparin serum lipoprotein lipase mass is negatively related to coronary atherosclerosis. Atherosclerosis 2000;153:391-6.
51. Ukkola O, Savolainen MJ, Salmela PI. DNA polymorphism at the lipoprotein lipase gene are associated with macroangiopathy in type 2 (non insulin dependent) diabetes mellitus. Atherosclerosis 1995;115:99-105.
52. Ukkola O, Garenc C, Pérusse L, et al. Genetic variation at the lipoprotein lipase locus and plasma lipoprotein and insulin levels in the Québec Family Study. Atherosclerosis 2001;158:199-206.